These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32942283)

  • 1. Implementing Cancer Genomics in State Health Agencies: Mapping Activities to an Implementation Science Outcome Framework.
    Green RF; Kumerow MT; Rodriguez JL; Addie S; Beachy SH; Senier L
    Public Health Genomics; 2020; 23(5-6):218-229. PubMed ID: 32942283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the role of public health in implementation of genomics-related recommendations: a case study of hereditary cancers using the CDC Science Impact Framework.
    Green RF; Ari M; Kolor K; Dotson WD; Bowen S; Habarta N; Rodriguez JL; Richardson LC; Khoury MJ
    Genet Med; 2019 Jan; 21(1):28-37. PubMed ID: 29907802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proposed outcomes measures for state public health genomic programs.
    Doyle DL; Clyne M; Rodriguez JL; Cragun DL; Senier L; Hurst G; Chan K; Chambers DA
    Genet Med; 2018 Sep; 20(9):995-1003. PubMed ID: 29300382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expert and Advocacy Group Consensus Findings on the Horizon of Public Health Genetic Testing.
    Modell SM; Greendale K; Citrin T; Kardia SL
    Healthcare (Basel); 2016 Jan; 4(1):. PubMed ID: 27417602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Activities and Impact of State Programs to Address Hereditary Breast and Ovarian Cancer, 2011-2014.
    Trivers KF; Rodriguez JL; Cox SL; Crane BE; Duquette D
    Healthcare (Basel); 2015 Oct; 3(4):948-63. PubMed ID: 27417805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using behaviour change and implementation science to address low referral rates in oncology.
    Long JC; Debono D; Williams R; Salisbury E; O'Neill S; Eykman E; Butler J; Rawson R; Phan-Thien KC; Thompson SR; Braithwaite J; Chin M; Taylor N
    BMC Health Serv Res; 2018 Nov; 18(1):904. PubMed ID: 30486812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementing universal Lynch syndrome screening (IMPULSS): protocol for a multi-site study to identify strategies to implement, adapt, and sustain genomic medicine programs in different organizational contexts.
    Rahm AK; Cragun D; Hunter JE; Epstein MM; Lowery J; Lu CY; Pawloski PA; Sharaf RN; Liang SY; Burnett-Hartman AN; Gudgeon JM; Hao J; Snyder S; Gogoi R; Ladd I; Williams MS
    BMC Health Serv Res; 2018 Oct; 18(1):824. PubMed ID: 30376847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leveraging Implementation Science to Address Health Disparities in Genomic Medicine: Examples from the Field.
    Roberts MC; Mensah GA; Khoury MJ
    Ethn Dis; 2019; 29(Suppl 1):187-192. PubMed ID: 30906168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initiation of universal tumor screening for Lynch syndrome in colorectal cancer patients as a model for the implementation of genetic information into clinical oncology practice.
    Cohen SA; Laurino M; Bowen DJ; Upton MP; Pritchard C; Hisama F; Jarvik G; Fichera A; Sjoding B; Bennett RL; Naylor L; Jacobson A; Burke W; Grady WM
    Cancer; 2016 Feb; 122(3):393-401. PubMed ID: 26480326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multilevel research and the challenges of implementing genomic medicine.
    Khoury MJ; Coates RJ; Fennell ML; Glasgow RE; Scheuner MT; Schully SD; Williams MS; Clauser SB
    J Natl Cancer Inst Monogr; 2012 May; 2012(44):112-20. PubMed ID: 22623603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges and Opportunities for Cancer Predisposition Cascade Screening for Hereditary Breast and Ovarian Cancer and Lynch Syndrome in Switzerland: Findings from an International Workshop.
    Nikolaidis C; Ming C; Pedrazzani C; van der Horst T; Kaiser-Grolimund A; Ademi Z; Bührer-Landolt R; Bürki N; Caiata-Zufferey M; Champion V; Chappuis PO; Kohler C; Erlanger TE; Graffeo R; Hampel H; Heinimann K; Heinzelmann-Schwarz V; Kurzeder C; Monnerat C; Northouse LL; Pagani O; Probst-Hensch N; Rabaglio M; Schoenau E; Sijbrands EJG; Taborelli M; Urech C; Viassolo V; Wieser S; Katapodi MC;
    Public Health Genomics; 2018; 21(3-4):121-132. PubMed ID: 30695780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing theory and non-theory based implementation approaches to improving referral practices in cancer genetics: a cluster randomised trial protocol.
    Morrow A; Hogden E; Kang YJ; Steinberg J; Canfell K; Solomon MJ; Kench JG; Gill AJ; Shaw T; Pachter N; Parkinson B; Wolfenden L; Mitchell G; Macrae F; Tucker K; Taylor N
    Trials; 2019 Jun; 20(1):373. PubMed ID: 31221211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing cancer control capacity in state and local public health agencies.
    Meissner HI; Bergner L; Marconi KM
    Public Health Rep; 1992; 107(1):15-23. PubMed ID: 1738803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extent of Pedigree Required to Screen for and Diagnose Hereditary Nonpolyposis Colorectal Cancer: Comparison of Simplified and Extended Pedigrees.
    Heo Y; Kim MH; Kim DW; Lee SA; Bang S; Kim MJ; Oh HK; Kang SB; Kang SI; Park JW; Ryoo SB; Jeong SY; Park KJ
    Dis Colon Rectum; 2020 Feb; 63(2):152-159. PubMed ID: 31842160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDC Grand Rounds: Family History and Genomics as Tools for Cancer Prevention and Control.
    Rodriguez JL; Thomas CC; Massetti GM; Duquette D; Avner L; Iskander J; Khoury MJ; Richardson LC
    MMWR Morb Mortal Wkly Rep; 2016 Nov; 65(46):1291-1294. PubMed ID: 27880748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementing a Learning Collaborative Framework for States Working to Improve Outcomes for Vulnerable Populations: The Opioid Use Disorder, Maternal Outcomes, and Neonatal Abstinence Syndrome Initiative Learning Community.
    Kroelinger CD; Addison D; Rodriguez M; Rice ME; Frey MT; Hickner HR; Weber MK; Mueller T; Velonis A; Uesugi K; Romero L; Akbarali S; Foster N; Ko JY; Pliska E; Mackie C; Cox S; Fehrenbach SN; Barfield WD
    J Womens Health (Larchmt); 2020 Apr; 29(4):475-486. PubMed ID: 32176568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The best practices: use of the guidelines by ten state tobacco control programs.
    Mueller NB; Luke DA; Herbers SH; Montgomery TP
    Am J Prev Med; 2006 Oct; 31(4):300-6. PubMed ID: 16979454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of state comprehensive cancer control plans for genomics content.
    Laufman JD; Duquette D; Trepanier A
    Prev Chronic Dis; 2012; 9():E176. PubMed ID: 23256909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Process evaluation of a behaviour change approach to improving clinical practice for detecting hereditary cancer.
    Long JC; Winata T; Debono D; Phan-Thien KC; Zhu C; Taylor N
    BMC Health Serv Res; 2019 Mar; 19(1):180. PubMed ID: 30894169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients.
    Snowsill T; Huxley N; Hoyle M; Jones-Hughes T; Coelho H; Cooper C; Frayling I; Hyde C
    BMC Cancer; 2015 Apr; 15():313. PubMed ID: 25910169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.